Dr. Rodney S. Daniel, MD

Dr. Daniel practices at American Arthritis & Rheumatology Associates in Boca Raton, Florida.

Dr. Daniel's NPI, 1912094822, was assigned on October 10, 2006. Dr. Daniel graduated from University of Miami, Miller School of Medicine in 2003. Dr. Daniel holds Florida license ME108707.

Dr. Daniel's primary practice is American Arthritis & Rheumatology Associates, at 2255 W Glades Rd, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (561) 747-1987.

Dr. Daniel's primary practice is American Arthritis & Rheumatology Associates in Boca Raton, Florida. Dr. Daniel is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is AARA (The American Arthritis and Rheumatology Associates). Dmand AI also links Dr. Daniel to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daniel practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Daniel's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Daniel is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Daniel's licenses on file in 2 states: Florida and South Carolina.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Daniel treats.

CMS data shows 248,413 Medicare services from Dr. Daniel across 22 procedure codes in 2024, for 386 Medicare patients. Medicare paid $2,138,356 for them. Every service was in an office.

CMS counts 386 Medicare patients who saw Dr. Daniel in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have arthritis, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Daniel's median patient age at 66, with 75% women.

In 2024, Dr. Daniel wrote 2,418 Medicare Part D claims for 445 patients. 79% of them were for generic drugs. CMS names the drug for 2,083 of them, across 42 drugs with 11 or more claims each, at $2,633,203 in total drug cost. In 2023, CMS named 2,084 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Daniel for performance year 2024, reported as part of a group. Dr. Daniel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Daniel, published from 2009 to 2011. The most frequent topics are Eosinophilia and Fasciitis. Dr. Daniel has published most often in Am J Med Sci. Dr. Daniel's most frequent co-authors are Nada Ghanimeh Abou-Fayssal, MD, Kenkichi Nozaki and David Edward Stickler, MD.

CMS Open Payments shows 3,199 general payments to Dr. Daniel from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Sanofi and Genzyme US Companies paid the most, $192,807. It also lists 1 research payment totaling $114 in 2024, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Daniel, most recently CMS Stage 1 EHR in 2013.

Dr. Daniel graduated from University of Miami, Miller School of Medicine in 2003. Dr. Daniel is a member of ACR.

Dr. Daniel is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.